retatrutide mechanism triple agonist glp-1 gip glucagon Is better than tirzepatide? vs dual compared LY3437943, a novel triple glucagon,

It is the first GLP-1 receptor agonist tablet for weight-loss to be approved by the Medicines and Healthcare products Regulatory Agency (MHRA), making the UK the third country to authorise the pills, behind the US and the United Arab Emirates

In February, researchers from the University of Leicester and the Leicester Diabetes Centre published a review article on obesity in the "International Journal of Obesity," introducing the current and future drug development pipeline for the treatment of obesity, with special attention given to novel therapies based on the mechanisms of gut incretin hormones

Tsai, S.-R., & Hamblin, M

Li X, Liu Q, Pan Y, Chen S, Zhao Y, Hu Y (2023) New insights into the role of dietary triglyceride absorption in obesity and metabolic diseases

Nucleus accumbens D1/D2 circuits control opioid withdrawal symptoms in mice

You dont have to use all the areas but make sure you rotate the injection site each week